Physician profile
Eric L Maranda
NPI 1205362043
$4,919.87
in general payments reported to CMS, 2019-2025
18 companies · $819 in 2025
The $819 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,647 · 2020: $223 · 2021: $134 · 2022: $324 · 2023: $981 · 2024: $792 · 2025: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,591.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,997.61 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $682.02 | 2019-2024 | Libtayo, Dupixent |
| Celgene Corporation | $267.34 | 2019 | |
| Genzyme Corporation | $261.12 | 2023-2025 | |
| Organogenesis INC. | $235.95 | 2023-2025 | Puraply, Cygnus Dual |
| Incyte Corporation | $227.47 | 2023-2024 | Opzelura |
| Amgen INC. | $222.29 | 2022-2025 | Otezla, Otezla |
| Pfizer INC. | $159.67 | 2019-2020 | |
| Janssen Biotech, INC. | $157.83 | 2021-2025 | Simponi Aria, Simponi, Tremfya |
| Merz North America, INC. | $145.46 | 2019 | |
| Sun Pharmaceutical Industries INC. | $143.23 | 2023 | |
| Kyowa Kirin, INC. | $109.88 | 2019 | |
| Novartis Pharmaceuticals Corporation | $72.04 | 2022-2025 | |
| Ucb, INC. | $66.78 | 2024-2025 | Bimzelx |
| Lilly USA, LLC | $61.91 | 2022-2025 | Taltz, Ebglyss, Olumiant |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.06 | 2023 | Cyltezo |
| Genentech USA, INC. | $30.69 | 2020-2024 | Xolair |
| Arcutis Biotherapeutics, INC. | $27.52 | 2023-2024 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Maranda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.